日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

伊马替尼治疗后慢性粒细胞白血病患者的继发性恶性肿瘤:CML IV 研究的长期观察

Miranda, M B; Lauseker, M; Kraus, M-P; Proetel, U; Hanfstein, B; Fabarius, A; Baerlocher, G M; Heim, D; Hossfeld, D K; Kolb, H-J; Krause, S W; Nerl, C; Brümmendorf, T H; Verbeek, W; Fauser, A A; Prümmer, O; Neben, K; Hess, U; Mahlberg, R; Plöger, C; Flasshove, M; Rendenbach, B; Hofmann, W-K; Müller, M C; Pfirrmann, M; Hochhaus, A; Hasford, J; Hehlmann, R; Saußele, S

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

伊马替尼一线治疗下,e13a2 与 e14a2 BCR-ABL1 驱动的慢性粒细胞白血病具有不同的特征

Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W; Schubert, Jörg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Spiekermann, Karsten; Baerlocher, Gabriela M; Pfirrmann, Markus; Hasford, Joerg; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Müller, Martin C

Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase

慢性期慢性粒细胞白血病患者中 BCR-ABL 转录水平与完全细胞遗传学缓解的等效性

Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas; Müller, Martin C

Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML)

慢性粒细胞白血病 (CML) 患者中转酮醇酶样基因 1 (TKTL1) 的表达取决于疾病阶段

Philipp, M; Schwaab, J; Dietz, C T; Hanfstein, B; Kalmanti, L; Munjal, U; Mossner, M; Nowak, D; Seifarth, W; Hofmann, W K; Hochhaus, A; Müller, M C; Erben, P

Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

尽管预后指标较差,但年轻的慢性粒细胞白血病患者预后良好:来自随机CML IV研究的结果

Kalmanti, Lida; Saussele, Susanne; Lauseker, Michael; Proetel, Ulrike; Müller, Martin C; Hanfstein, Benjamin; Schreiber, Annette; Fabarius, Alice; Pfirrmann, Markus; Schnittger, Susanne; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Spiekermann, Karsten; Krause, Stefan W; Heim, Dominik; Nerl, Christoph; Hossfeld, Dieter K; Kolb, Hans-Jochem; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV

一项随机CML-Study IV亚组分析显示,老年慢性粒细胞白血病患者(≥65岁)比年轻患者更能从较高剂量的伊马替尼治疗中获益。

Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrman, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger; Saußele, Susanne

Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group

老年急性早幼粒细胞白血病患者的预后:德国急性髓系白血病协作组的研究结果

Lengfelder, Eva; Hanfstein, Benjamin; Haferlach, Claudia; Braess, Jan; Krug, Utz; Spiekermann, Karsten; Haferlach, Torsten; Kreuzer, Karl-Anton; Serve, Hubert; Horst, Heinz A; Schnittger, Susanne; Aul, Carlo; Schultheis, Beate; Erben, Philipp; Schneider, Stephanie; Müller-Tidow, Carsten; Wörmann, Bernhard; Berdel, Wolfgang E; Sauerland, Cristina; Heinecke, Achim; Hehlmann, Rüdiger; Hofmann, Wolf-Karsten; Hiddemann, Wolfgang; Büchner, Thomas

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity

在表达T315I-BCR-ABL的细胞中,ABL抑制剂诱导的MAPK激活增强:白血病发生改变的潜在机制

Härtel, Nicolai; Klag, Thomas; Hanfstein, Benjamin; Mueller, Martin C; Schenk, Thomas; Erben, Philipp; Hochhaus, Andreas; La Rosée, Paul

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

酪氨酸激酶抑制剂治疗停止后突变型 BCR-ABL 阳性克隆的动态变化

Hanfstein, Benjamin; Müller, Martin C; Kreil, Sebastian; Ernst, Thomas; Schenk, Thomas; Lorentz, Christian; Schwindel, Uwe; Leitner, Armin; Hehlmann, Rüdiger; Hochhaus, Andreas